| Name | Datopotamab |
|---|
| Description | Datopotamab (CDP7657) is an antibody targeting to TROP2. Datopotamab can be used to synthesize Datopotamab deruxtecan (HY-141598), TROP2-directed antibody-drug conjugate (ADC). Datopotamab deruxtecan consists of DNA topoisomerase I inhibitor Deruxtecan (HY-13631E) and Datopotamab[1]. |
|---|---|
| Related Catalog | |
| Target |
TROP2[1] |
| References |
| No Any Chemical & Physical Properties |